These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17549819)
1. Point:Counterpoint "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction". Lahm T; Meldrum DR J Appl Physiol (1985); 2007 May; 102(5):2077-8; discussion 2080. PubMed ID: 17549819 [No Abstract] [Full Text] [Related]
2. Point:Counterpoint "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction". Wadsworth RM J Appl Physiol (1985); 2007 May; 102(5):2077; discussion 2080. PubMed ID: 17549818 [No Abstract] [Full Text] [Related]
3. Point:Counterpoint "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction". Packer CS; Pelaez NJ J Appl Physiol (1985); 2007 May; 102(5):2078-9; discussion 2080. PubMed ID: 17549821 [No Abstract] [Full Text] [Related]
4. Point:Counterpoint: "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction". Madden JA J Appl Physiol (1985); 2007 May; 102(5):2077; discussion 2080. PubMed ID: 17483444 [No Abstract] [Full Text] [Related]
5. Point:Counterpoint "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction". Yuan JX J Appl Physiol (1985); 2007 May; 102(5):2078; discussion 2080. PubMed ID: 17549820 [No Abstract] [Full Text] [Related]
6. Point: release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction. Robertson TP J Appl Physiol (1985); 2007 May; 102(5):2071-2; discussion 2075-6. PubMed ID: 17095630 [No Abstract] [Full Text] [Related]
7. Counterpoint: release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are not the main effectors for full and sustained HPV. Rochefort GY; Michelakis ED J Appl Physiol (1985); 2007 May; 102(5):2072-5; discussion 2075, 2080. PubMed ID: 17483441 [No Abstract] [Full Text] [Related]
8. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Jernigan NL; Walker BR; Resta TC Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L515-29. PubMed ID: 18621909 [TBL] [Abstract][Full Text] [Related]
9. Postnatal maturational shift from PKCzeta and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction. Cogolludo A; Moreno L; Lodi F; Tamargo J; Perez-Vizcaino F Cardiovasc Res; 2005 Apr; 66(1):84-93. PubMed ID: 15769451 [TBL] [Abstract][Full Text] [Related]
10. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. Sauzeau V; Rolli-Derkinderen M; Lehoux S; Loirand G; Pacaud P Circ Res; 2003 Oct; 93(7):630-7. PubMed ID: 12946946 [TBL] [Abstract][Full Text] [Related]
11. Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C. Barman SA Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L472-9. PubMed ID: 17468135 [TBL] [Abstract][Full Text] [Related]
12. Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Wang Z; Jin N; Ganguli S; Swartz DR; Li L; Rhoades RA Am J Respir Cell Mol Biol; 2001 Nov; 25(5):628-35. PubMed ID: 11713106 [TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation. Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588 [TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species and RhoA signaling in vascular smooth muscle: role in chronic hypoxia-induced pulmonary hypertension. Resta TC; Broughton BR; Jernigan NL Adv Exp Med Biol; 2010; 661():355-73. PubMed ID: 20204742 [TBL] [Abstract][Full Text] [Related]
16. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Gohla A; Schultz G; Offermanns S Circ Res; 2000 Aug; 87(3):221-7. PubMed ID: 10926873 [TBL] [Abstract][Full Text] [Related]
17. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. Nagaoka T; Gebb SA; Karoor V; Homma N; Morris KG; McMurtry IF; Oka M J Appl Physiol (1985); 2006 Mar; 100(3):996-1002. PubMed ID: 16322374 [TBL] [Abstract][Full Text] [Related]
18. Role of the G-protein and tyrosine kinase--Rho/ROK pathways in 15-hydroxyeicosatetraenoic acid induced pulmonary vasoconstriction in hypoxic rats. Wang Y; Liang D; Wang S; Qiu Z; Chu X; Chen S; Li L; Nie X; Zhang R; Wang Z; Zhu D J Biochem; 2010 May; 147(5):751-64. PubMed ID: 20139061 [TBL] [Abstract][Full Text] [Related]
19. Vasoconstriction, RhoA/Rho-kinase and the erectile response. Mills TM; Lewis RW; Wingard CJ; Linder AE; Jin L; Webb RC Int J Impot Res; 2003 Oct; 15 Suppl 5():S20-4. PubMed ID: 14551573 [TBL] [Abstract][Full Text] [Related]